Publikationen
Zeitschriftenartikel (31)
1.
Zeitschriftenartikel
131, 103969 (2024)
SUMOylation modulates mitochondrial dynamics in an in vitro rotenone model of Parkinson's disease. Molecular and Cellular Neuroscience 2.
Zeitschriftenartikel
13 (11), 939 (2024)
Dose-Dependent Cognitive Decline, Anxiety, and Locomotor Impairments Induced by Doxorubicin: Evidence from an Animal Model. Biology 3.
Zeitschriftenartikel
64 (21), S. 8215 - 8226 (2024)
Impact of Phosphorylation on the Physiological Form of Human alpha-Synuclein in Aqueous Solution. Journal of Chemical Information and Modeling 4.
Zeitschriftenartikel
8 (1), S. 83 - 98 (2024)
Stress granules formation in HEI-OC1 auditory cells and in H4 human neuroglioma cells secondary to cisplatin exposure. Cell Stress 5.
Zeitschriftenartikel
25 (20), e202400253 (2024)
Synthesis and Semi-Synthesis of Alpha-Synuclein: Insight into the Chemical Complexity of Synucleinopathies. Chembiochem 6.
Zeitschriftenartikel
One-step nanoscale expansion microscopy reveals individual protein shapes. Nature Biotechnology (2024)
7.
Zeitschriftenartikel
32 (10), S. 3372 - 3401 (2024)
A small TAT-TrkB peptide prevents BDNF receptor cleavage and restores synaptic physiology in Alzheimer's disease. Molecular Therapy 8.
Zeitschriftenartikel
20 (10), S. 6776 - 6792 (2024)
Cellular prion protein acts as mediator of amyloid beta uptake by caveolin‐1 causing cellular dysfunctions in vitro and in vivo. Alzheimer's & Dementia 9.
Zeitschriftenartikel
364, 143039 (2024)
A versatile yeast model identifies the pesticides cymoxanil and metalaxyl as risk factors for synucleinopathies. Chemosphere 10.
Zeitschriftenartikel
168 (8), S. 1608 - 1624 (2024)
Is it all the RAGE? Defining the role of the receptor for advanced glycation end products in Parkinson's disease. Journal of Neurochemistry 11.
Zeitschriftenartikel
168 (8), S. 1514 - 1526 (2024)
Altered hippocampal doublecortin expression in Parkinson's disease. Journal of Neurochemistry 12.
Zeitschriftenartikel
168 (8), S. 1625 - 1639 (2024)
PrP meets alpha-synuclein: Molecular mechanisms and implications for disease. Journal of Neurochemistry 13.
Zeitschriftenartikel
14 (5), S. 917 - 924 (2024)
Diabetes and Parkinson's Disease: Understanding Shared Molecular Mechanisms. Journal of Parkinson's Disease 14.
Zeitschriftenartikel
23 (7), S. 669 (2024)
Abandon the NAC in α-synuclein. Lancet Neurology 15.
Zeitschriftenartikel
18, 1412450 (2024)
Age-related alterations in efferent medial olivocochlear-outer hair cell and primary auditory ribbon synapses in CBA/J mice. Frontiers in Cellular Neuroscience 16.
Zeitschriftenartikel
14 (4), S. 681 - 692 (2024)
Automated Capillary Electrophoresis Immunoblot for the Detection of Alpha-Synuclein in Mouse Tissue. Journal of Parkinson's Disease: JPD 17.
Zeitschriftenartikel
39 (6), S. 1080 - 1081 (2024)
Reply to: “Rethinking Parkinson's Disease: A Syndromic Perspective”. Movement Disorders 18.
Zeitschriftenartikel
39 (6), S. 929 - 933 (2024)
Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice. Movement Disorders 19.
Zeitschriftenartikel
49, S. 1643 - 1654 (2024)
Physical Exercise-Induced Activation of NRF2 and BDNF as a Promising Strategy for Ferroptosis Regulation in Parkinson’s Disease. Neurochemical Research 20.
Zeitschriftenartikel
122, 106078 (2024)
Towards a biological diagnosis of PD. Parkinsonism & Related Disorders 21.
Zeitschriftenartikel
23 (5), e14128 (2024)
Inhibition of 26S proteasome activity by α-synuclein is mediated by the proteasomal chaperone Rpn14/PAAF1. Aging Cell 22.
Zeitschriftenartikel
39 (4), S. 321 - 328 (2024)
Novel multifunctional nanoliposomes inhibit α-synuclein fibrillization, attenuate microglial activation, and silence the expression of SNCA gene. Neurología (English Edition) 23.
Zeitschriftenartikel
15 (4), 264 (2024)
α-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrPC-CCR5 dependent pathway. Cell Death and Disease 24.
Zeitschriftenartikel
31, S. 3797 - 3804 (2024)
Adsorption of alpha-synuclein and inhibition of fibril formation by nanocellulose and gold-coated-nanocellulose. Cellulose 25.
Zeitschriftenartikel
22, S. 2670 - 2676 (2024)
Chemical synthesis of site-selective advanced glycation end products in α-synuclein and its fragments. Organic & Biomolecular Chemistry 26.
Zeitschriftenartikel
125 (3), e30523 (2024)
In silico analysis of alpha‐synuclein protein variants and posttranslational modifications related to Parkinson's disease. Journal of Cellular Biochemistry 27.
Zeitschriftenartikel
121 (2), e2309700120 (2024)
Substitution of Met-38 to Ile in γ-synuclein found in two patients with amyotrophic lateral sclerosis induces aggregation into amyloid. PNAS 28.
Zeitschriftenartikel
13 (1), e6900 (2024)
Uncovering potential diagnostic and pathophysiological roles of α-synuclein and DJ-1 in melanoma. Cancer Medicine 29.
Zeitschriftenartikel
147 (1), S. 81 - 90 (2024)
Aggregation and beyond: alpha-synuclein-based biomarkers in synucleinopathies. Brain 30.
Zeitschriftenartikel
147 (1), 40 (2024)
Regional AT-8 reactive tau species correlate with intracellular Aβ levels in cases of low AD neuropathologic change. Acta Neuropathologica 31.
Zeitschriftenartikel
18, S. 68 - 71 (2024)
Prion meeting 2023: implications of a growing field. Prion Editorial (2)
32.
Editorial
168 (8), S. 1421 - 1683 (2024)
Aging and neurodegeneration: From molecular mechanisms to therapeutic interventions. Journal of Neurochemistry 33.
Editorial
15, 1399709 (2024)
One health care in psychiatric and neurological diseases. Frontiers in Psychiatry